Access to anti-retroviral drugs, male in Romania

Romania: Access to anti-retroviral drugs, male was 89.0% in 2024. ▲ Rising

Latest (2024)
89.0%
Change on year
up 9.9%
World rank
17th
of 141 countries
All-time high
89.0%
in 2024
All-time low
28.0%
in 2000
Years of data
25
2000–2024

Access to anti-retroviral drugs, male in Romania, 2000–2024

204060802000201220242000: 28 %2001: 34 %2002: 38 %2003: 40 %2004: 41 %2005: 42 %2006: 44 %2007: 43 %2008: 44 %2009: 45 %2010: 45 %2011: 47 %2012: 48 %2013: 58 %2014: 61 %2015: 65 %2016: 64 %2017: 67 %2018: 70 %2019: 73 %2020: 73 %2021: 75 %2022: 78 %2023: 81 %2024: 89 %

Source: UNAIDS estimates. Measured in %.

Analysis

The most recent figure for access to anti-retroviral drugs, male in Romania is 89.0%, measured in 2024. That is the highest value across all 25 years on record.

The figure is up 9.9% on the previous year and up 45.9% over ten years.

Over the whole period, access to anti-retroviral drugs, male in Romania peaked at 89.0% in 2024 and was at its lowest, 28.0%, in 2000.

Romania ranks 17th of 141 countries on this measure, in the top quarter.

The long-run direction has been consistently rising across the 25 years of available data.

Access to anti-retroviral drugs, male in Romania, year by year

Annual values for Access to anti-retroviral drugs, male (%) in Romania, 2000 to 2024.
Year % Change
2000 28.0%
2001 34.0% +21.4%
2002 38.0% +11.8%
2003 40.0% +5.3%
2004 41.0% +2.5%
2005 42.0% +2.4%
2006 44.0% +4.8%
2007 43.0% -2.3%
2008 44.0% +2.3%
2009 45.0% +2.3%
2010 45.0% +0.0%
2011 47.0% +4.4%
2012 48.0% +2.1%
2013 58.0% +20.8%
2014 61.0% +5.2%
2015 65.0% +6.6%
2016 64.0% -1.5%
2017 67.0% +4.7%
2018 70.0% +4.5%
2019 73.0% +4.3%
2020 73.0% +0.0%
2021 75.0% +2.7%
2022 78.0% +4.0%
2023 81.0% +3.8%
2024 89.0% +9.9%

Averages by decade

DecadeAverage LowestHighest Years
2000s 39.9% 28.0% 45.0% 10
2010s 59.8% 45.0% 73.0% 10
2020s 79.2% 73.0% 89.0% 5

Countries ranked near Romania

  1. 17 France 89.0% compare
  2. 17 Iceland 89.0% compare
  3. 17 Ireland 89.0% compare
  4. 17 Netherlands 89.0% compare
  5. 17 Zimbabwe 89.0% compare

See the full ranking of 160 places →

More gender data for Romania

All data for Romania →

Frequently asked questions

What is access to anti-retroviral drugs, male in Romania?
Access to anti-retroviral drugs, male in Romania was 89.0% in 2024, according to UNAIDS estimates.
What is the highest access to anti-retroviral drugs, male recorded in Romania?
The highest recorded value was 89.0% in 2024.
What is the lowest access to anti-retroviral drugs, male recorded in Romania?
The lowest recorded value was 28.0% in 2000.
How does Romania rank for access to anti-retroviral drugs, male?
Romania ranks 17th out of 141 countries with data for 2024.
Is access to anti-retroviral drugs, male rising or falling in Romania?
Over the last ten years it is up 45.9%. The long-run trend across the full record is rising.
Where does this Romania data come from?
The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Access to anti-retroviral drugs, male in Romania. Statizoid, drawing on UNAIDS estimates. Retrieved 10 September 2026, from https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/romania/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/romania/">Access to anti-retroviral drugs, male in Romania</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, male (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,923 data points, 2000–2024
Last refreshed

The percentage of adult males living with HIV who are receiving antiretroviral therapy.